Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May:61:103774.
doi: 10.1016/j.msard.2022.103774. Epub 2022 Mar 25.

The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis

Affiliations
Review

The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis

Manuela Altieri et al. Mult Scler Relat Disord. 2022 May.

Abstract

Background: Covid-19 pandemic caused relevant psychological consequences in the general population. Since people with Multiple Sclerosis (pwMS) are usually at higher risk of psychological distress than age-matched healthy controls (HC), a meta-analytic study was conducted, aimed at evaluating i) differences between pwMS and HC in the psychological variables during the pandemic, ii) differences in the levels of anxiety, depression, stress, sleep disturbances and quality of life before and during the Covid-19 pandemic in pwMS.

Methods: The literature search on three electronic databases yielded 196 studies (113 after the duplicates removal). Seven studies compared psychological variables between pwMS and HC during the pandemic, while seven studies evaluated the pre- vs during the pandemic differences in pwMS. The following outcomes were selected: depression, anxiety, physical QoL, mental QoL, stress, sleep quality/disturbances. Mean weighted effect sizes (ES) were calculated using Hedges'g, via Prometa3 software.

Results: During the pandemic, pwMS showed higher levels of depression (g = 0.51, p=.001), anxiety (g = 0.41, p=.032), and stress (g = 0.51, p=.016) compared to HC. The comparison on psychological outcomes before and during the pandemic in pwMS revealed no significant increase during the pandemic on levels of anxiety (g = 0.08, p=.380), depression (g = 0.02, p=.772), mental QoL (g= -0.14, p=.060), physical QoL (g = 0.00, p=.986), whereas sleep quality deteriorated during the pandemic (g = 0.52, p<.001).

Conclusions: In agreement with pre-pandemic literature, pwMS showed higher levels of psychological distress than HC also during the Covid-19 pandemic. Contrariwise, longitudinal studies revealed that, in pwMS, the only psychological-associated variable that worsened significantly was the sleep quality, but this outcome was evaluated only in two studies. Future studies will have to assess/evaluate the long-term psychological consequences of the pandemic on pwMS.

Keywords: Anxiety; Covid-19; Depression; Multiple sclerosis; QoL; Sleep.

PubMed Disclaimer

Conflict of interest statement

MA, RC, AdA, DB and GS have no disclosures. AB has received speaker honoraria and/or compensation for consulting service from Biogen, Merck and Genzyme. GT has received compensation for consulting services and/or speaking activities from Biogen, Novartis, Merck, Genzyme, Roche, Teva; and receives research support from Biogen Idec, Merck Serono, and Fondazione Italiana Sclerosi Multipla. AG received honoraria for speaking and travel grants from Merck, Genzyme, Teva, Mylan, Roche and Novartis.

Figures

Fig. 1
Fig. 1
Study selection process. PRISMA flowchart.
Fig. 2
Fig. 2
Meta-analysis on comparison of levels of psychological distress between pwMS and HC during the 2020 Covid-19 lockdown. Forest plots for (A) anxiety, (B) depression, (C) stress, (D) sleep disturbances. ES = effect size; 95% CI = confidence intervals; Sig = statistical significance; N = total sample size.
Fig. 3
Fig. 3
Meta-analysis on the comparison of levels of psychological distress in pwMS before and during the 2020 Covid-19 lockdown. Forest plots for (A) anxiety, (B) depression, (C) mental QoL, (D) physical QoL, (E) sleep disturbances. ES = effect size; 95% CI = confidence intervals; Sig = statistical significance; N = total sample size.

References

    1. Al-Rahimi J.S., Nass N.M., Hassoubah S.A., Wazqar D.Y., Alamoudi S.A. Levels and predictors of fear and health anxiety during the current outbreak of COVID-19 in immunocompromised and chronic disease patients in Saudi Arabia: a cross-sectional correlational study. PLoS ONE. 2021;16 doi: 10.1371/journal.pone.0250554. - DOI - PMC - PubMed
    1. Andreu-Caravaca L., Ramos-Campo D., Manonelles P., Abellán-Aynés O., Chung L.H., Rubio-Arias J.Á. Effect of COVID-19 home confinement on sleep monitorization and cardiac autonomic function in people with multiple sclerosis: a prospective cohort study. Physiol. behav. 2021;237 doi: 10.1016/j.physbeh.2021.113392. - DOI - PMC - PubMed
    1. Bamer A., Johnson K., Amtmann D., Kraft G. Prevalence of sleep problems in individuals with multiple sclerosis. Multiple Sclerosis Journal. 2008;14:1127–1130. doi: 10.1177/1352458508092807. - DOI - PMC - PubMed
    1. Boeschoten R.E., Braamse A.M.J., Beekman A.T.F., Cuijpers P., van Oppen P., Dekker J., Uitdehaag B.M.J. Prevalence of depression and anxiety in Multiple Sclerosis: a systematic review and meta-analysis. J. Neurol. Sci. 2017;372:331–341. doi: 10.1016/j.jns.2016.11.067. - DOI - PubMed
    1. Bonavita S., Sparaco M., Russo A., Borriello G., Lavorgna L. Perceived stress and social support in a large population of people with multiple sclerosis recruited online through the COVID-19 pandemic. Eur. J. Neurol. 2020 doi: 10.1111/ene.14697. - DOI - PubMed